🚀 go-pugleaf

Here is an extract from the granted US patent 6,048,553 for that
water.  Similar patent have been given in Australia and elsewhere.

For more info go to  http://164.195.100.11/netahtml/srchnum.htm and
enter the above number.

TECHNICAL FIELD 

This invention relates to an aqueous metal bicarbonate solution, a
process of preparing the aqueous metal bicarbonate solution and a
method of preventing and treating certain inflammatory diseases,
degenerative diseases and viral diseases in mammals.

Generally the certain inflammatory diseases, degenerative diseases and
viral diseases in mammals are those that require extracellular or
intracellular acidic conditions or extracellular or intracellular
proton concentrations at some point in disease process or disease
pathogenesis.

Typically the certain inflammatory diseases, degenerative diseases and
viral diseases in mammals are those that require the activities of
carbonic anhydrase enzymes and/or the activities of acid (aspartic)
protease enzymes and/or the activities of endosomal or lysosomal
acid-requiring-enzymes and/or the activities of V-type ATPase proton
pumps at some point in disease process or disease pathogenesis.
Typically the certain inflammatory diseases, degenerative diseases and
viral diseases in mammals are represented by the diseases of arthritis
and influenza;

This invention relates to a method of using an aqueous metal
bicarbonate solution to decrease senescence and to increase longevity
in mammals. Generally senescence is decreased and longevity is
increased in mammals by improving the buffering capacity of the
extracellular and intracellular fluids of the body. Generally
senescence is decreased and longevity is increased in mammals by the
improved buffering capacity causing a decrease in proton
concentrations in the extracellular and intracellular fluids of the
body.

Typically senescence is decreased and longevity is increased in
mammals by improving the buffering capacity of the extracellular and
intracellular bicarbonate buffers. Typically senescence is decreased
and longevity is increased in mammals by the improved extracellular
and intracellular bicarbonate buffers causing a decrease in proton
concentrations.

BACKGROUND ART 

Certain inflammatory diseases, degenerative diseases and viral
diseases are major causes of morbidity and mortality in mammals.
Typically these diseases are represented by the diseases of arthritis
and influenza.

Arthritis is any inflammatory condition of the joints, characterised
by pain and swelling. Osteoarthritis is the most common form of
arthritis in which one or many joins undergo degenerative changes.
Treatment includes rest of the involved joints, heat, and
antiinflammatory drugs. Intraarticular injections of corticosteroids
may give relief. Surgical treatment is sometimes necessary and may
reduce pain and greatly improve the function of the joint. However
these treatments, apart from surgical treatment, only provide
temporary relief and some may have severe side reactions.

Influenza is a highly contagious infection of the respiratory tract
caused by a myxovirus and transmitted by airborne droplet infection.
It occurs in isolated cases, epidemics and pandemics Treatment is
symptomatic and usually involves bed rest, antipyretics such as
aspirin and drinking of fluids. New strains of the virus emerge at
regular intervals so it is difficult to take preventative measures to
avoid the infection There is a need for a method to prevent and to
treat certain inflammatory diseases, degenerative diseases and viral
diseases in mammals. There is a need for a method to prevent and to
treat arthritis and influenza in mammals.

Senescence in mammals is characterised by progressive oxidations of
the structural and functional molecules that constitute body cells and
tissues. Oxidations of the structural and functional molecules in body
cells and tissues are increased in rate by acidic conditions.
Oxidations of structural and functional molecules are increased in
rate by the presence of excess proton concentrations. There is a need
for a method to prevent and treat excess proton concentrations in body
cells so that oxidations of structural and functional molecules are
decreased in rate. There is a need for a method to decrease and treat
senescence in mammals.

OBJECTS OF INVENTION 

It is an object of this invention to provide an aqueous metal
bicarbonate solution to prevent and to treat certain inflammatory
diseases, degenerative diseases and viral diseases in mammals. It is a
further object of this invention to provide a process of preparing the
aqueous metal bicarbonate solution. It is also an object of this
invention to provide methods for the prevention and treatment of
certain inflammatory diseases, degenerative diseases and viral
diseases in mammals using the aqueous metal bicarbonate solution.
Generally the certain inflammatory diseases, degenerative diseases and
viral diseases in mammals are those that require extracellular or
intracellular acidic conditions or extracellular or intracellular
proton concentrations at some point in disease process or disease
pathogenesis. Typically the certain inflammatory diseases,
degenerative diseases and viral diseases in mammals are those that
require the activities of carbonic anhydrase enzymes and/or the
activities of acid (aspartic) protease enzymes and/or the activities
of endosomal or lysosommal acid-requiring-enzymes and/or the
activities of V-type ATPase proton pumps at some point in disease
process or disease pathogenesis. Typically the certain inflammatory
diseases, degenerative diseases and viral diseases in mammals are
represented by the diseases of arthritis and influenza.

It is an object of this invention to provide an aqueous metal
bicarbonate solution to decrease senescence and to treat senescence
and to increase longevity in mammals. It is a further object of this
invention to provide a process of preparing the aqueous metal
bicarbonate solution. It is also an object of this invention to
provide methods for the decrease of senescence and the treatment of
senescence and the increase in longevity in mammals using the aqueous
metal bicarbonate solution. Generally senescence is decreased and
longevity is increased in mammals by improving the buffering capacity
of the extracellular and intracellular fluids of the body. Generally
senescence is decreased and longevity is increased in mammals by the
improved buffering capacity causing a decrease in proton
concentrations in the extracellular and intracellular fluids of the
body. Typically senescence is decreased and longevity is increased in
mammals by improving the buffering capacity of the extracellular and
intracellular bicarbonate buffers. Typically senescence is decreased
and longevity is increased in mammals by the improved extracellular
and intracellular bicarbonate buffers causing a decrease in proton
concentrations.